Drug
Low Dose
Low Dose: highest development phase Phase 1, developed by EnnovaBio. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- EnnovaBio
Trials
| Drug | Phase | Indication |
|---|---|---|
| Low Dose, 10%BSA NCT07684196 | Phase 1 |
Latest
No recent events.
Follow Low Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.